States Luring Scientists With Salaries, Facilities

Although such appropriations and bond issues promise to foster excellence throughout the state, the primary beneficiaries of much pump priming are usually state colleges and universities. These efforts, in turn, have triggered recruitment wars between established research institutions and newer programs trying to join the top echelon. The bidding is particularly fierce in such fields as ceramics, computers, chemical engineering and all aspects of biotechnology. And although higher salaries alo

Written byAnne Moffat
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The bidding is particularly fierce in such fields as ceramics, computers, chemical engineering and all aspects of biotechnology. And although higher salaries alone are rarely sufficient to trigger such a move, the new buildings and equipment that are made possible with such special appropriations offer a powerful lure to some faculty.

Edward Arnold rejected offers from Cornell and the University of Pennsylvania to accept a position of assistant professor at the Center for Advanced Biotechnology and Medicine (CABM), a unit ofRutgers University and the University of Medicine and Dentistry of New Jersey. "It's exciting to be part of a nucleus of a new center and to help in deciding how things will progress," said Arnold, a structural biologist. "I am the third of 18 new faculty to be recruited, and I can help shape further hiring."

The absence of formal teaching duties was another inducement, Arnold said. The state-supported CABM ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies